Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |